We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
Cap. Flow
-$137M
Cap. Flow %
-0.37%
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$297M
2
CELG
Celgene Corp
CELG
+$277M
3
USB icon
US Bancorp
USB
+$190M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$154M
5
XOM icon
ExxonMobil
XOM
+$150M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$259M
2
DD icon
DuPont de Nemours
DD
+$255M
3
BA icon
Boeing
BA
+$243M
4
MO icon
Altria Group
MO
+$234M
5
UNP icon
Union Pacific
UNP
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 15.5%
2 Technology 15.03%
3 Consumer Discretionary 14.19%
4 Industrials 12.34%
5 Consumer Staples 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVA
2501
DELISTED
Sinovac Biotech, Ltd
SVA
-30,400
Closed -$214K
ENV
2502
DELISTED
ENVESTNET, INC.
ENV
-3,926
Closed -$200K
CZR
2503
DELISTED
Caesars Entertainment Corporation
CZR
-169,293
Closed -$2.26M
DDC
2504
DELISTED
Dominion Diamond Corporation
DDC
-161,646
Closed -$2.29M
TCF
2505
DELISTED
TCF Financial Corporation
TCF
-25,154
Closed -$429K

Similar funds

Two Sigma Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
  • Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
  • Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
  • Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
  • Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
  • Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
  • Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.

Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.